Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player

Acquisition

Video: Valeant buys rights to Visudyne Add to ...

Valeant Pharmaceuticals has purchased the rights to Visudyne, an eye drug, from Vancouver-based QLT Inc.

Drive

Technology

In the know

More from The Globe and Mail

Most Popular Stories